Diana F. Hausman - 14 Jan 2022 Form 4 Insider Report for Immuneering Corp (IMRX)

Role
Director
Signature
/s/ Michael D. Bookman, Attorney-in-Fact for Diana F. Hausman
Issuer symbol
IMRX
Transactions as of
14 Jan 2022
Net transactions value
+$327,600
Form type
4
Filing time
18 Jan 2022, 07:21:47 UTC
Next filing
23 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMRX Stock Option Award $327,600 +25,200 $13.00 25,200 14 Jan 2022 Class A Common Stock 25,200 $13.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable in equal monthly installments over a three year period commencing on February 14, 2022, and will be fully vested and exercisable on January 14, 2025.